Cargando…

Parkinson’s disease laterality: a (11)C-PE2I PET imaging study

Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Roussakis, Andreas-Antonios, Zeng, Zhou, Lao-Kaim, Nicholas P., Martin-Bastida, Antonio, Piccini, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880931/
https://www.ncbi.nlm.nih.gov/pubmed/32880071
http://dx.doi.org/10.1007/s00415-020-10204-y
_version_ 1783650771391217664
author Roussakis, Andreas-Antonios
Zeng, Zhou
Lao-Kaim, Nicholas P.
Martin-Bastida, Antonio
Piccini, Paola
author_facet Roussakis, Andreas-Antonios
Zeng, Zhou
Lao-Kaim, Nicholas P.
Martin-Bastida, Antonio
Piccini, Paola
author_sort Roussakis, Andreas-Antonios
collection PubMed
description Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriate clinical assessments. (11)C-PE2I non-displaceable binding potential (BP(ND)) was calculated bilaterally for the striatum at baseline and follow-up to estimate the in vivo density of striatal dopamine transporters (DAT). Changes in striatal (11)C-PE2I BP(ND) over time were more prominent in the ipsilateral as compared to contralateral side. Changes in MDS-UPDRS-III (motor component of the Movement Disorders Society Unified PD Rating Scale) were not different between the clinically most and least affected body sides. Our data support that the asymmetry in striatal dopaminergic degeneration becomes less prominent in moderate-stage PD. In contrast, during the above period, the asymmetry of motor symptoms was maintained between the clinically most and least affected body sides.
format Online
Article
Text
id pubmed-7880931
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78809312021-02-18 Parkinson’s disease laterality: a (11)C-PE2I PET imaging study Roussakis, Andreas-Antonios Zeng, Zhou Lao-Kaim, Nicholas P. Martin-Bastida, Antonio Piccini, Paola J Neurol Original Communication Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriate clinical assessments. (11)C-PE2I non-displaceable binding potential (BP(ND)) was calculated bilaterally for the striatum at baseline and follow-up to estimate the in vivo density of striatal dopamine transporters (DAT). Changes in striatal (11)C-PE2I BP(ND) over time were more prominent in the ipsilateral as compared to contralateral side. Changes in MDS-UPDRS-III (motor component of the Movement Disorders Society Unified PD Rating Scale) were not different between the clinically most and least affected body sides. Our data support that the asymmetry in striatal dopaminergic degeneration becomes less prominent in moderate-stage PD. In contrast, during the above period, the asymmetry of motor symptoms was maintained between the clinically most and least affected body sides. Springer Berlin Heidelberg 2020-09-02 2021 /pmc/articles/PMC7880931/ /pubmed/32880071 http://dx.doi.org/10.1007/s00415-020-10204-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Communication
Roussakis, Andreas-Antonios
Zeng, Zhou
Lao-Kaim, Nicholas P.
Martin-Bastida, Antonio
Piccini, Paola
Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
title Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
title_full Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
title_fullStr Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
title_full_unstemmed Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
title_short Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
title_sort parkinson’s disease laterality: a (11)c-pe2i pet imaging study
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880931/
https://www.ncbi.nlm.nih.gov/pubmed/32880071
http://dx.doi.org/10.1007/s00415-020-10204-y
work_keys_str_mv AT roussakisandreasantonios parkinsonsdiseaselateralitya11cpe2ipetimagingstudy
AT zengzhou parkinsonsdiseaselateralitya11cpe2ipetimagingstudy
AT laokaimnicholasp parkinsonsdiseaselateralitya11cpe2ipetimagingstudy
AT martinbastidaantonio parkinsonsdiseaselateralitya11cpe2ipetimagingstudy
AT piccinipaola parkinsonsdiseaselateralitya11cpe2ipetimagingstudy
AT parkinsonsdiseaselateralitya11cpe2ipetimagingstudy